The singer and flutist hopped on Instagram Live to break down how she lost weight and what she does to ensure she focuses on ...

The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

Skye Bioscience currently trades essentially at cash value, meaning investors who buy in today get a weight loss drug ...

Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing ...

Tracye Craven, 65, was at her highest weight after losing her job and her father — but a wake-up call at the doctor led her to prioritize her health and look past her 'real good excuses' to get ...

The virtual nutrition care startup just raised a $70 million Series B funding round, and it's profitable, BI has learned ...

Danish drugmaker Novo Nordisk A/S (CPH: NOVO-B) lost more than 10% last week after its US rival Eli Lilly & Co (NYSE: LLY) reported encouraging Phase 3 data for its oral weight-loss treatment. ...

Drugs firms argue that NICE ’s thresholds are too stingy. Medicines made up around 9% of health spending in Britain in 2018, ...